VolitionRx announces $2.3M registered direct offering; insiders buy 2.36M shares at $0.55

VOLITIONRX LTD

2,363,636 shares sold to insiders (directors, officers, existing stockholders) at $0.55/share.
1,739,087 shares + warrants (exercise $0.66, 5-year) sold to other investors at $0.55 combined.
Gross proceeds $2.3M upfront; up to $1.1M additional if warrants fully exercised.
Net proceeds for R&D, clinical studies, product commercialization, and working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.